These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 21782913

  • 1. Sustained release of 5-fluorouracil by incorporation into sodium carboxymethylcellulose sub-micron fibers.
    Cai X, Luan Y, Dong Q, Shao W, Li Z, Zhao Z.
    Int J Pharm; 2011 Oct 31; 419(1-2):240-6. PubMed ID: 21782913
    [Abstract] [Full Text] [Related]

  • 2. Nanogels fabricated by lysozyme and sodium carboxymethyl cellulose for 5-fluorouracil controlled release.
    Zhu K, Ye T, Liu J, Peng Z, Xu S, Lei J, Deng H, Li B.
    Int J Pharm; 2013 Jan 30; 441(1-2):721-7. PubMed ID: 23089579
    [Abstract] [Full Text] [Related]

  • 3. Layer-by-layer assembly of poly(L-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil.
    Yan S, Zhu J, Wang Z, Yin J, Zheng Y, Chen X.
    Eur J Pharm Biopharm; 2011 Aug 30; 78(3):336-45. PubMed ID: 21195174
    [Abstract] [Full Text] [Related]

  • 4. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
    Lin Q, Cai Y, Yuan M, Ma L, Qiu M, Su J.
    Oncol Rep; 2014 Dec 30; 32(6):2405-10. PubMed ID: 25231485
    [Abstract] [Full Text] [Related]

  • 5. Carboxymethylcellulose-coated 5-fluorouracil@MOF-5 nano-hybrid as a bio-nanocomposite carrier for the anticancer oral delivery.
    Javanbakht S, Hemmati A, Namazi H, Heydari A.
    Int J Biol Macromol; 2020 Jul 15; 155():876-882. PubMed ID: 31805324
    [Abstract] [Full Text] [Related]

  • 6. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V, Denora N, Lopalco A, Lopedota A, Cutrignelli A, Lasorsa FM, Agostino G, Franco M.
    Mol Pharm; 2014 Mar 03; 11(3):859-71. PubMed ID: 24410438
    [Abstract] [Full Text] [Related]

  • 7. Layered nanohydroxyapatite as a novel nanocarrier for controlled delivery of 5-fluorouracil.
    Luo H, Ji D, Li C, Zhu Y, Xiong G, Wan Y.
    Int J Pharm; 2016 Nov 20; 513(1-2):17-25. PubMed ID: 27596116
    [Abstract] [Full Text] [Related]

  • 8. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model.
    Safwat MA, Soliman GM, Sayed D, Attia MA.
    Mol Pharm; 2018 Jun 04; 15(6):2194-2205. PubMed ID: 29701979
    [Abstract] [Full Text] [Related]

  • 9. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
    Rajan M, Raj V, Al-Arfaj AA, Murugan AM.
    Int J Pharm; 2013 Sep 10; 453(2):514-22. PubMed ID: 23796828
    [Abstract] [Full Text] [Related]

  • 10. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
    Emeje MO, Kunle OO, Ofoefule SI.
    Acta Pharm; 2006 Sep 10; 56(3):325-35. PubMed ID: 19831281
    [Abstract] [Full Text] [Related]

  • 11. Nanoporous multilayer poly(L-glutamic acid)/chitosan microcapsules for drug delivery.
    Yan S, Rao S, Zhu J, Wang Z, Zhang Y, Duan Y, Chen X, Yin J.
    Int J Pharm; 2012 May 10; 427(2):443-51. PubMed ID: 22301425
    [Abstract] [Full Text] [Related]

  • 12. pH-Controlled drug delivery with hybrid aerogel of chitosan, carboxymethyl cellulose and graphene oxide as the carrier.
    Wang R, Shou D, Lv O, Kong Y, Deng L, Shen J.
    Int J Biol Macromol; 2017 Oct 10; 103():248-253. PubMed ID: 28526342
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of thermo-sensitive CS-g-PNIPAM/CMC complex nanoparticles for controlled release of 5-FU.
    Zhang T, Li G, Guo L, Chen H.
    Int J Biol Macromol; 2012 Dec 10; 51(5):1109-15. PubMed ID: 22981819
    [Abstract] [Full Text] [Related]

  • 14. Study on hydrophilic 5-fluorouracil release from hydrophobic poly(ε-caprolactone) cylindrical implants.
    Hou J, Li C, Cheng L, Guo S, Zhang Y, Tang T.
    Drug Dev Ind Pharm; 2011 Sep 10; 37(9):1068-75. PubMed ID: 21449700
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of 5-fluorouracil encapsulated in zeolites as drug delivery systems for in vitro models of colorectal carcinoma.
    Vilaça N, Amorim R, Machado AF, Parpot P, Pereira MF, Sardo M, Rocha J, Fonseca AM, Neves IC, Baltazar F.
    Colloids Surf B Biointerfaces; 2013 Dec 01; 112():237-44. PubMed ID: 23988779
    [Abstract] [Full Text] [Related]

  • 16. Self-assembling peptide nanofibers containing phenylalanine for the controlled release of 5-fluorouracil.
    Ashwanikumar N, Kumar NA, Saneesh Babu PS, Sivakumar KC, Vadakkan MV, Nair P, Hema Saranya I, Asha Nair S, Vinod Kumar GS.
    Int J Nanomedicine; 2016 Dec 01; 11():5583-5594. PubMed ID: 27822037
    [Abstract] [Full Text] [Related]

  • 17. Green encapsulation of LDH(Zn/Al)-5-Fu with carboxymethyl cellulose biopolymer; new nanovehicle for oral colorectal cancer treatment.
    Pooresmaeil M, Behzadi Nia S, Namazi H.
    Int J Biol Macromol; 2019 Oct 15; 139():994-1001. PubMed ID: 31401278
    [Abstract] [Full Text] [Related]

  • 18. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer.
    Ahmad MZ, Akhter S, Anwar M, Ahmad FJ.
    Mol Pharm; 2012 Nov 05; 9(11):2986-94. PubMed ID: 22994847
    [Abstract] [Full Text] [Related]

  • 19. Preparation and in vitro evaluation of 5-flourouracil loaded magnetite-zeolite nanocomposite (5-FU-MZNC) for cancer drug delivery applications.
    Sağir T, Huysal M, Durmus Z, Kurt BZ, Senel M, Isık S.
    Biomed Pharmacother; 2016 Feb 05; 77():182-90. PubMed ID: 26796283
    [Abstract] [Full Text] [Related]

  • 20. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
    Glavas Dodov M, Calis S, Crcarevska MS, Geskovski N, Petrovska V, Goracinova K.
    Int J Pharm; 2009 Nov 03; 381(2):166-75. PubMed ID: 19580856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.